Uncategorized

Epack Prefab’s order book stood at ₹655 crore as of the first half of FY26, the company said.

Most of these companies have the US as their largest client base, with 50% to 70% of their overall topline coming from the world’s biggest consumer market.

Biocon Biologics, a fully-integrated global biosimilars company, said it received approval for the Yesintek and Yesintek IV (ustekinumab injection), a biosimilar to Stelara IV on October 17.

Gold’s latest dip is less about weakness and more about a natural breather after a record-breaking run. A stronger dollar, cautious sentiment, and shifting geopolitical tone have triggered short-term selling — but the long-term outlook for gold remains positive.

In its exchange filing, the company stated that the capital could be raised through equity shares or other securities, including private placement, qualified institutions placement (QIP), preferential issue, or any other method, or through multiple methods.

UBS expects a major rebound in Titan’s earnings, underpinned by its strong brand equity, deep consumer trust, and a manageable threat from lab-grown diamonds.

At the end of the September quarter, promoters of Infosys had a 14.3% stake in the company. The entitlement ratio, record date, and other dates of the share buyback are yet to be announced by the company.

Similar to Morgan Stanley, Goldman Sachs also believes that the strength of the company’s business model and outlook is already reflected in the premium valuations at which the company trades at.

The cyber incident has emerged as a drag on JLR’s performance and is expected to weigh on output in the current quarter.

In prior interactions, the management of JSW Steel had hinted on lower iron ore prices. The price cuts were anticipated but the quantum is higher than expectations, according to analysts.